Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models

  1. Marrocco, I.
  2. Romaniello, D.
  3. Vaknin, I.
  4. Drago-Garcia, D.
  5. Oren, R.
  6. Uribe, M.L.
  7. Belugali Nataraj, N.
  8. Ghosh, S.
  9. Eilam, R.
  10. Salame, T.-M.
  11. Lindzen, M.
  12. Yarden, Y.
Zeitschrift:
EMBO Molecular Medicine

ISSN: 1757-4684,  1757-4676

Datum der Publikation: 2021

Ausgabe: 13

Nummer: 4

Art: Artikel

DOI: 10.15252/EMMM.202013144 GOOGLE SCHOLAR lock_openOpen Access editor